RNS Number : 1963F
W.H. Ireland Group PLC
29 October 2025
 

29 October 2025

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 (MAR) as in force in the United Kingdom pursuant to the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via Regulatory Information Service (RIS), this inside information is now considered to be in the public domain.

WH Ireland Group Plc

 

("WH Ireland" or the "Company"

and with its subsidiaries the "Group")

Deferred Consideration re Capital Markets Division

WH Ireland today announces that its subsidiary, WH Ireland Limited, has now received £1.1m, being the full and final payment due to it under the terms of the asset purchase agreement made between WH Ireland Limited and Zeus Capital Limited, for the sale of the WH Ireland Capital Markets Division (the "Transaction"). Full details of the Transaction are set out in the Company's announcements dated 3 June 2024 and 15 July 2024.  

The consideration was calculated by reference to the retainer and transaction revenue generated by the Capital Markets Division within the 12 months after completion of the Transaction.

The cash proceeds will be retained by the Group and utilised for general corporate purposes.

 

For further information please contact:

WH Ireland Group plc  

www.whirelandplc.com

Simon Jackson, Chief Finance Officer

+44(0) 20 7220 1666



Zeus Capital Limited (Nominated Adviser and broker)

www.zeuscapital.co.uk

Katy Mitchell / Harry Ansell / James Bavister      

+44(0) 161 831 1512



MHP

whireland@mhpgroup.com

Reg Hoare / Hugo Harris               

+44 (0) 7831 406117

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPGCWUUPAGBR